» Articles » PMID: 37490047

Prevalence and Risk Factors of Diabetic Peripheral Neuropathy: A Population-based Cross-sectional Study In China

Overview
Specialty Endocrinology
Date 2023 Jul 25
PMID 37490047
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To assess the prevalence of diabetic peripheral neuropathy (DPN) and its risk factors in the type 2 diabetes mellitus (T2DM) population.

Methods: This cross-sectional study enroled patients with T2DM between July and December 2017 from 24 provinces in China. Diabetic peripheral neuropathy and its severity were assessed by the Toronto clinical scoring system, neuropathy symptoms score (NSS) and neuropathy disability score. The prevalence of DPN and its risk factors were analysed.

Results: A total of 14,908 patients with T2DM were enroled. The prevalence of DPN was 67.6%. Among 10,084 patients with DPN, 4808 (47.7%), 3325 (33.0%), and 1951 (19.3%) had mild, moderate, and severe DPN, respectively. The prevalence of DPN in females was higher than in males (69.0% vs. 66.6%, P = 0.002). The prevalence of DPN increased with age and course of diabetes and decreased with body mass index (BMI) and education level (all P for trend <0.05). The comorbidities and complications in patients with DPN were higher than in those without DPN, including hypertension, myocardial infarction, diabetic retinopathy, and diabetic nephropathy (all P < 0.001). Age, hypertension, duration of diabetes, diabetic retinopathy, diabetic nephropathy, glycated haemoglobin, high-density lipoprotein cholesterol, and lower estimated glomerular filtration rate were positively associated with DPN, while BMI, education level, fasting C-peptide, and uric acid were negatively associated with DPN.

Conclusions: Among patients with T2DM in China, the prevalence of DPN is high, especially in the elderly, low-income, and undereducated patients.

Citing Articles

Diabetic peripheral neuropathy detection of type 2 diabetes using machine learning from TCM features: a cross-sectional study.

Tian Z, Zhang J, Fan Y, Sun X, Wang D, Liu X BMC Med Inform Decis Mak. 2025; 25(1):90.

PMID: 39966886 PMC: 11837659. DOI: 10.1186/s12911-025-02932-w.


Correlation between diabetic peripheral neuropathy and thyroid hormone sensitivity in elderly patients with type 2 diabetes mellitus.

Fei S, Luo J, Wang W, Guo L, Pan Q World J Diabetes. 2025; 16(2):98897.

PMID: 39959265 PMC: 11718484. DOI: 10.4239/wjd.v16.i2.98897.


Glucagon: a potential protective factor against peripheral nerve compromise in patients with type 2 diabetes and obesity.

Hua H, Wang R, Xu Y, Xu F, Wang C, Zhao L Diabetol Metab Syndr. 2025; 17(1):35.

PMID: 39876008 PMC: 11773760. DOI: 10.1186/s13098-025-01601-2.


Construction and validation of a nomogram model for predicting diabetic peripheral neuropathy.

Liu H, Liu Q, Chen M, Lu C, Feng P Front Endocrinol (Lausanne). 2024; 15:1419115.

PMID: 39736870 PMC: 11682957. DOI: 10.3389/fendo.2024.1419115.


Clinical Trial: Effect of Autologous Dendritic Cell Administration on Improving Neuropathy Symptoms and Inflammatory Biomarkers in Diabetic Neuropathy.

Setiawan E, Ginting C, Jonny J, Hernowo B, Putranto T Curr Issues Mol Biol. 2024; 46(12):14366-14380.

PMID: 39727989 PMC: 11674235. DOI: 10.3390/cimb46120861.